CalciMedica (CALC) Accounts Payables (2019 - 2026)
CalciMedica's (CALC) quarterly Accounts Payables came in at $1.7 million in Q1 2026, down 16.91% YoY from $2.0 million in Q1 2025, and up 44.27% on a QoQ basis from $1.2 million in Q4 2025.
CalciMedica (CALC) Accounts Payables (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Accounts Payables data on file, last reported at $1.7 million in Q1 2026.
- Quarterly Accounts Payables fell 16.91% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 16.91% YoY) and the FY2025 annual result came in at $1.2 million, down 41.89% from the prior year.
- Accounts Payables grew to $1.7 million in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $2.9 million in Q4 2022 to a low of $498000.0 in Q3 2022.
- A 5-year average of $1.6 million and a median of $1.5 million in 2024 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 443.83% in 2022, down 75.9% in 2022.
- Tracing CALC's Accounts Payables over 5 years: stood at $2.9 million in 2022, then sank by 50.49% to $1.4 million in 2023, then jumped by 40.8% to $2.0 million in 2024, then sank by 41.89% to $1.2 million in 2025, then soared by 44.27% to $1.7 million in 2026.
- The last three Accounts Payables figures came in at $1.7 million (Q1 2026), $1.2 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 35.57 Mn |
| 10 | CalciMedica | 9.95 Mn | -8.67 Mn | - | 2.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.07 Mn |
| Mar 31, 2026 | 1.68 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 2.02 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 1.74 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 2.87 Mn |
| Sep 30, 2022 | 498,000.00 |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 541,000.00 |
| Dec 31, 2021 | 527,000.00 |
| Sep 30, 2021 | 2.07 Mn |